Wilson Sonsini Goodrich & Rosati advised Terray on the transaction. Terray Therapeutics (Terray), a biotechnology company, announced raising $120 million in Series B funding round. The...
You must be a Standard 1 Year member to access this content.
Paul Weiss Rifkind Wharton & Garrison is advising IBM on the transaction, and Wilson Sonsini Goodrich & Rosati is advising HashiCorp. IBM (NYSE: IBM) and HashiCorp Inc....
You must be a Standard 1 Year member to access this content.
Gibson, Dunn & Crutcher advised Montrose Environmental Group, Inc. on the offering, and Wilson Sonsini Goodrich & Rosati advised the underwriters. Montrose Environmental Group, Inc. (NYSE:...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Rambus in the transaction. Rambus Inc. (NASDAQ: RMBS) announced that it initiated an accelerated share repurchase program with Royal Bank of Canada...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Alector in the offering, and Davis Polk & Wardwell represented the sole book-running manager and underwriter, Cantor Fitzgerald & Co....
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Alector, Inc. in the offering, and Davis Polk & Wardwell represented TD Cowen, as sales agent. Alector, Inc. (“Alector”) (Nasdaq:ALEC)...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised ALX Oncology Holdings Inc. on the offering, and Cooley advised the underwriters. ALX Oncology Holdings Inc. (Nasdaq:ALXO) announced the pricing...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Nextdata on the transaction. Nextdata announced it has raised a total of $12 million in seed investment, led by Greycroft and Acrew Capital, with participation...
You must be a Standard 1 Year member to access this content.
Fox Rothschild LLP is acting as legal advisor to Cyclo Therapeutics and Wilson Sonsini Goodrich & Rosati, P.C. is acting as legal advisor to Applied Molecular...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati is representing Rambus on the transaction. Rambus Inc. (NASDAQ: RMBS) announced that it initiated an accelerated share repurchase program with Royal Bank of...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised Cadence, and Wilson Sonsini Goodrich & Rosati advised Rambus on the transaction. Cadence Design Systems, Inc. and Rambus Inc. announced that they have entered...
You must be a Standard 1 Year member to access this content.
Sidley Austin LLP advised Pyxis Oncology, Inc. on the transaction, while Wilson Sonsini advised Apexigen on the transaction. Pyxis Oncology, Inc., a clinical-stage company, and Apexigen,...
You must be a Standard 1 Year member to access this content.
